Experimental Drug for Partial Epilepsy

What we are studying

The purpose of this research study is to evaluate the safety and efficacy of an experimental drug for people with partial epilepsy (having seizures that affect only part of the brain) over a one year period of time. The experimental drug is being tested as a monotherapy (single medication) for people with partial epilepsy not well controlled by other antiepileptic drugs (AEDs).

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 16 - 70

Eligibility Criteria

  • Have Epilepsy
  • Must have participated in either 093-045 or 093-046

What is involved

  • 1 year initial time commitment with an option of continuing study drug treatment beyond 1 year
  • Must have participated in the previous study


$100.00 for each completed visit until the end of the study

Contact Information

Study Coordinator
Jessica Dimos

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.